Publications by authors named "Claudio Sini"

Claim this Profile
A
Advanced-stage ALK-positive non-small-cell lung cancer (NSCLC) patients: Real-world treatment patterns and outcomes from the Italian biomarker ATLAS database.
Maria Lucia Reale, Daniela Scattolin, Antonio Vitale, Francesco Passiglia, Salvatore Grisanti, Claudio Sini

Lung Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone metastases in NSCLC: Modern paradigms in management and supportive care.
Gabriele Minuti, Giorgia Pasqualini, Alice Avancini, Niccolò Giaj-Levra, Francesca Colonese, Claudio Sini

Cancer Treat Rev· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world outcomes of subsequent treatment strategies after durvalumab consolidation in stage III unresectable non-small cell lung cancer.
Veronica Crespi, Marco Donatello Delcuratolo, Gabriele Minuti, Michele Montrone, Sara Pilotto, Claudio Sini

Lung Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Actionable NSCLC Mutation Identification by Comprehensive Genomic Profiling for Clinical Trial Enrollment: The European Program for the Routine Testing of Patients With Advanced Lung Cancer (EPROPA).
Francesco Passiglia, Angela Listì, Paolo Bironzo, Alessandra Merlini, Federica Benso, Claudio Sini

J Thorac Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current diagnostic and therapeutical approaches to bone metastases in patients with non-small cell lung cancer: A cross-sectional study.
Alice Avancini, Niccolò Giaj-Levra, Gabriele Minuti, Giorgia Pasqualini, Francesca Colonese, Claudio Sini

Lung Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Narrative medicine in patients with cancer during intravenous antiblastic therapy: a qualitative study.
Valentina Micheluzzi, Francesco Burrai, Antonella Delogu, Maria Giovanna Schintu, Teresa Pira, Claudio Sini

Support Care Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter Re: Indirect comparison of capmatinib treatment from GEOMETRY mono-1 trial to SOC in German patients with locally advanced or metastatic NSCLC harboring METex14 skipping mutations.
Claudio Sini, Alessandro Di Federico, Paolo Bironzo, Andrea De Giglio, Francesco Gelsomino

Eur J Cancer· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete Blood Count-Based Biomarkers as Predictors of Clinical Outcomes in Advanced Non-Small Cell Lung Cancer Patients with PD-L1 < 50% Treated with First-Line Chemoimmunotherapy.
Carlo Putzu, Riccardo Serra, Rachele Campus, Giovanni Maria Fadda, Claudio Sini

Curr Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sotorasib in KRASp.G12C mutated advanced NSCLC: Real-world data from the Italian expanded access program.
Francesco Passiglia, Maria Lucia Reale, Giuseppe Lo Russo, Giulia Pasello, Gabriele Minuti, Claudio Sini

Lung Cancer· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation-Related Deregulation of TUBB3 and BRCA1/2 and Risk of Secondary Lung Cancer in Women With Breast Cancer.
Simona Coco, Simona Boccardo, Marco Mora, Vincenzo Fontana, Irene Vanni, Claudio Sini

Clin Breast Cancer· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precision Medicine for NSCLC in the Era of Immunotherapy: New Biomarkers to Select the Most Suitable Treatment or the Most Suitable Patient.
Giovanni Rossi, Alessandro Russo, Marco Tagliamento, Alessandro Tuzi, Olga Nigro, Claudio Sini

Cancers (Basel)· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concomitant medications during immune checkpoint blockage in cancer patients: Novel insights in this emerging clinical scenario.
Giovanni Rossi, Aldo Pezzuto, Claudio Sini, Alessandro Tuzi, Fabrizio Citarella

Crit Rev Oncol Hematol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second line therapy with axitinib after only prior sunitinib in metastatic renal cell cancer: Italian multicenter real world SAX study final results.
Gaetano Facchini, Sabrina Rossetti, Massimiliano Berretta, Carla Cavaliere, Sarah Scagliarini, Claudio Sini

J Transl Med· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of EGFR TKIs in Caucasian Patients With NSCLC Harboring Potentially Sensitive Uncommon EGFR Mutations.
Antonio Passaro, Arsela Prelaj, Laura Bonanno, Marcello Tiseo, Alessandro Tuzi, Claudio Sini

Clin Lung Cancer· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated Somatic and Germline Whole-Exome Sequencing Analysis in Women with Lung Cancer after a Previous Breast Cancer.
Simona Coco, Silvia Bonfiglio, Davide Cittaro, Irene Vanni, Marco Mora, Claudio Sini

Cancers (Basel)· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acquired resistance in oncogene-addicted non-small-cell lung cancer.
Claudio Sini, Alessandro Tuzi, Giovanni Rossi, Alessandro Russo, Aldo Pezzuto

Future Oncol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy.
Simona Coco, Angela Alama, Irene Vanni, Vincenzo Fontana, Carlo Genova, Claudio Sini

Int J Mol Sci· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of Ribonucleotide Reductase Subunit-2 and Thymidylate Synthase Correlates with Poor Prognosis in Patients with Resected Stages I-III Non-Small Cell Lung Cancer.
Francesco Grossi, Maria Giovanna Dal Bello, Sandra Salvi, Roberto Puzone, Ulrich Pfeffer, Claudio Sini

Dis Markers· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Afatinib resistance in non-small cell lung cancer involves the PI3K/AKT and MAPK/ERK signalling pathways and epithelial-to-mesenchymal transition.
Simona Coco, Anna Truini, Angela Alama, Maria Giovanna Dal Bello, Roberta Venè, Claudio Sini

Target Oncol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next generation sequencing in non-small cell lung cancer: new avenues toward the personalized medicine.
Simona Coco, Anna Truini, Irene Vanni, Maria Giovanna Dal Bello, Angela Alama, Claudio Sini

Curr Drug Targets· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral vinorelbine in the treatment of non-small-cell lung cancer.
Giulia Barletta, Carlo Genova, Erika Rijavec, Giovanni Burrafato, Federica Biello, Claudio Sini

Expert Opin Pharmacother· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of immunotherapy in the treatment of advanced non-small-cell lung cancer.
Erika Rijavec, Carlo Genova, Angela Alama, Giulia Barletta, Claudio Sini

Future Oncol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Free drugs in clinical trials and their potential cost saving impact on the National Health Service: a retrospective cost analysis in Italy.
Francesco Grossi, Carlo Genova, Nidia Diaz Gaitan, Maria Giovanna Dal Bello, Erika Rijavec, Claudio Sini

Lung Cancer· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pemetrexed for the treatment of non-small cell lung cancer.
Carlo Genova, Erika Rijavec, Anna Truini, Simona Coco, Claudio Sini

Expert Opin Pharmacother· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glyceraldehyde-3-phosphate dehydrogenase gene over expression correlates with poor prognosis in non small cell lung cancer patients.
Roberto Puzone, Graziana Savarino, Sandra Salvi, Maria Giovanna Dal Bello, Giulia Barletta, Claudio Sini

Mol Cancer· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis